Found: 137
Select item for more details and to access through your institution.
Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): Clinical efficacy in high-risk patients.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 4, p. 243, doi. 10.1002/ajh.21630
- By:
- Publication type:
- Article
One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 10, p. 787, doi. 10.1002/ajh.20689
- By:
- Publication type:
- Article
Structural deterioration of finger joints with ultrasonographic synovitis in rheumatoid arthritis patients with clinical low disease activity.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Structural deterioration of finger joints with ultrasonographic synovitis in rheumatoid arthritis patients with clinical low disease activity.
- Published in:
- Rheumatology, 2014, v. 53, n. 9, p. 1608, doi. 10.1093/rheumatology/keu154
- By:
- Publication type:
- Article
Sonographic synovial vascularity of synovitis in rheumatoid arthritis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Sonographic synovial vascularity of synovitis in rheumatoid arthritis.
- Published in:
- Rheumatology, 2014, v. 53, n. 4, p. 586, doi. 10.1093/rheumatology/ket311
- By:
- Publication type:
- Article
Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint.
- Published in:
- Rheumatology, 2013, v. 52, n. 3, p. 523, doi. 10.1093/rheumatology/kes310
- By:
- Publication type:
- Article
Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease.
- Published in:
- Rheumatology, 2012, v. 51, n. 10, p. 1765, doi. 10.1093/rheumatology/kes149
- By:
- Publication type:
- Article
Characteristics and pathogenic role of anti-β2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome.
- Published in:
- International Immunology, 1999, v. 11, n. 12, p. 1917, doi. 10.1093/intimm/11.12.1917
- By:
- Publication type:
- Article
A wide spectrum of collagen vascular and autoimmune diseases in transgenic rats carrying the env-pX gene of human T lymphocyte virus type I.
- Published in:
- International Immunology, 1997, v. 9, n. 2, p. 339, doi. 10.1093/intimm/9.2.339
- By:
- Publication type:
- Article
Investigation of the change in marker geometry during respiration motion: a preliminary study for dynamic-multi-leaf real-time tumor tracking.
- Published in:
- Radiation Oncology, 2012, v. 7, n. 1, p. 1, doi. 10.1186/1748-717X-7-218
- By:
- Publication type:
- Article
Investigation of the change in marker geometry during respiration motion: a preliminary study for dynamic-multi-leaf real-time tumor tracking.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat.
- Published in:
- 1993
- By:
- Publication type:
- journal article
T-lymphocyte-receptor repertoire of infiltrating T lymphocytes into NOD mouse pancreas.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis.
- Published in:
- Rheumatology International, 2012, v. 32, n. 6, p. 1511, doi. 10.1007/s00296-010-1784-8
- By:
- Publication type:
- Article
Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study.
- Published in:
- Rheumatology International, 2012, v. 32, n. 6, p. 1617, doi. 10.1007/s00296-011-1807-0
- By:
- Publication type:
- Article
Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance.
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 5, p. 747, doi. 10.1080/14397595.2018.1524998
- By:
- Publication type:
- Article
Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance.
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 5, p. 737, doi. 10.1080/14397595.2018.1510759
- By:
- Publication type:
- Article
Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study.
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 2, p. 314, doi. 10.1080/14397595.2018.1460230
- By:
- Publication type:
- Article
Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120.
- Published in:
- Modern Rheumatology, 2018, v. 28, n. 5, p. 770, doi. 10.1080/14397595.2017.1404731
- By:
- Publication type:
- Article
Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan.
- Published in:
- Modern Rheumatology, 2017, v. 27, n. 5, p. 755, doi. 10.1080/14397595.2016.1265695
- By:
- Publication type:
- Article
Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 5, p. 642, doi. 10.3109/14397595.2016.1141740
- By:
- Publication type:
- Article
Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 4, p. 491, doi. 10.3109/14397595.2015.1123211
- By:
- Publication type:
- Article
Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 4, p. 481, doi. 10.3109/14397595.2015.1109762
- By:
- Publication type:
- Article
Post-hoc analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 4, p. 473, doi. 10.3109/14397595.2015.1109182
- By:
- Publication type:
- Article
Prevention of joint destruction in patients with high disease activity or high C-reactive protein levels: Post hoc analysis of the GO-FORTH study.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 3, p. 323, doi. 10.3109/14397595.2015.1086041
- By:
- Publication type:
- Article
Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 1, p. 80, doi. 10.3109/14397595.2015.1060665
- By:
- Publication type:
- Article
Safety, pharmacokinetics, and pharmacodynamics of epratuzumab in Japanese patients with moderate-to-severe systemic lupus erythematosus: Results from a phase 1/2 randomized study.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 1, p. 87, doi. 10.3109/14397595.2015.1079292
- By:
- Publication type:
- Article
Professor Norman Talal 1934-2015.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 4, p. 664, doi. 10.3109/14397595.2015.1052683
- By:
- Publication type:
- Article
Trend of patient characteristics and its impact on the response to adalimumab in patients with rheumatoid arthritis: post hoc time-course analysis of an all-case PMS in Japan.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 4, p. 495, doi. 10.3109/14397595.2014.994263
- By:
- Publication type:
- Article
Decreased expression of Runx1 and lowered proportion of Foxp3<sup>+</sup> CD25<sup>+</sup> CD4<sup>+</sup> regulatory T cells in systemic sclerosis.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 1, p. 90, doi. 10.3109/14397595.2014.899736
- By:
- Publication type:
- Article
Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 1, p. 43, doi. 10.3109/14397595.2014.926607
- By:
- Publication type:
- Article
Early response to certolizumab pegol predicts long-term outcomes in patients with active rheumatoid arthritis: results from the Japanese studies.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 1, p. 11, doi. 10.3109/14397595.2014.904475
- By:
- Publication type:
- Article
Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: 52-week results from an open-label extension of the J-RAPID study.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 5, p. 734, doi. 10.3109/14397595.2014.881709
- By:
- Publication type:
- Article
Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 5, p. 715, doi. 10.3109/14397595.2013.864224
- By:
- Publication type:
- Article
Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 5, p. 725, doi. 10.3109/14397595.2013.865822
- By:
- Publication type:
- Article
Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: The HIKARI randomized, placebo-controlled trial.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 4, p. 552, doi. 10.3109/14397595.2013.843764
- By:
- Publication type:
- Article
Analysis of the factors which influence the measurement of synovial power Doppler signals with semi-quantitative and quantitative measures - a pilot multicenter exercise in Japan.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 3, p. 419, doi. 10.3109/14397595.2013.843763
- By:
- Publication type:
- Article
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 3, p. 390, doi. 10.3109/14397595.2013.843760
- By:
- Publication type:
- Article
A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 1, p. 1, doi. 10.3109/14397595.2013.852834
- By:
- Publication type:
- Article
Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 2, p. 284, doi. 10.3109/s10165-012-0657-2
- By:
- Publication type:
- Article
A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 2, p. 297, doi. 10.3109/s10165-012-0658-1
- By:
- Publication type:
- Article
Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 1, p. 81, doi. 10.3109/s10165-012-0642-9
- By:
- Publication type:
- Article
A case of catastrophic antiphospholipid antibody syndrome complicated with systemic lupus erythematosus, double positive for anti-cardiolipin/β glycoprotein I and anti-phosphatidylserine/prothrombin autoantibodies.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 5, p. 769, doi. 10.3109/s10165-011-0563-z
- By:
- Publication type:
- Article
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 4, p. 498, doi. 10.3109/s10165-011-0541-5
- By:
- Publication type:
- Article
Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 3, p. 382, doi. 10.1007/s10165-011-0534-4
- By:
- Publication type:
- Article